Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
16 hedge funds and large institutions have $1.25M invested in Genetic Technologies Ltd. in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
33% more funds holding
Funds holding: 12 → 16 (+4)
3% more capital invested
Capital invested by funds: $1.22M → $1.25M (+$35K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$106K |
| 2 |
VF
Virtu Financial
New York
|
+$54.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$25.8K |
| 4 |
Jane Street
New York
|
+$19.5K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$17.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.02M | -$2.31K | -80 | -0.2% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $99K | +$106K | +3,678 | +346% |
|
|
VF
3
Virtu Financial
New York
| $39K | +$54.2K | +1,875 | New |
|
|
AGM
4
Alpine Global Management
New York
| $30K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $19K | +$25.8K | +893 | New |
|
|
6
Jane Street
New York
| $14K | +$19.5K | +676 | New |
|
|
7
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $12K | +$17.3K | +600 | New |
|
8
Parallax Volatility Advisers
San Francisco,
California
| $5K | – | – | – |
|
|
CG
9
Cutler Group
San Francisco,
California
| $4K | – | – | – |
|
|
LTFS
10
Ladenburg Thalmann Financial Services
Miami,
Florida
| $3K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $3K | +$2.02K | +70 | +70% |
|
12
Morgan Stanley
New York
| $2K | – | – | – |
|
13
Simplex Trading
Chicago,
Illinois
| $1K | +$1.71K | +59 | +236% |
|
|
RE
14
RBC Europe
London,
United Kingdom
| $83 | – | – | – |
|
GENE Hedge Fund Activity: Q1 2018 in Review
16 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q1 2018, worth a combined $1.25M — up 2.9% from $1.22M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GENE positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $106K. The largest seller was Renaissance Technologies, cutting an estimated $2.31K.
- 16 institutional investors held Genetic Technologies Ltd. (GENE) as of Q1 2018, up from 12 in Q4 2017.
- Funds reported $1.25M of Genetic Technologies Ltd. stock for Q1 2018, up 2.9% quarter-over-quarter.
- 4 funds opened new Genetic Technologies Ltd. positions in Q1 2018 and 0 closed out, a net change of +4 holders.
- The largest Genetic Technologies Ltd. buyer in Q1 2018 was Susquehanna International Group, an estimated $106K added.
- The largest Genetic Technologies Ltd. seller in Q1 2018 was Renaissance Technologies, an estimated $2.31K sold.
Based on aggregated 13F filings for Q1 2018.